Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 Jun;85(12):4441–4445. doi: 10.1073/pnas.85.12.4441

Recognition of galactosylgloboside by monoclonal antibodies derived from patients with primary lung cancer.

D S Schrump 1, K Furukawa 1, H Yamaguchi 1, K O Lloyd 1, L J Old 1
PMCID: PMC280445  PMID: 2837767

Abstract

Lymph node lymphocytes from patients with primary lung cancer were immortalized with Epstein-Barr virus, and culture supernatants were screened for cell-surface reactivity against allogeneic cancer cell lines. The percentage of wells containing detectable antibodies in initial screening ranged from 1 to 17%, but the vast majority of the cultures lost antibody activity on subsequent expansion. Two antibody-secreting clones, J309 and D579, derived from separate individuals and reactive with anaplastic lung cancer cell lines, were successfully expanded and fused with the NS-1 mouse myeloma cell line. The antibodies produced by these clones exhibited identical restricted serologic reactivity against cultured cell lines and detected a carbohydrate antigen present in the neutral glycolipid fraction of MCF-7 breast cancer cells. Serologic, immunochemical, and chemical analyses revealed that the antigen recognized by antibodies J309 and D579 is galactosylgloboside [Gal(beta 1----3)GalNAc(beta 1----3)Gal(alpha 1----4)Gal(beta 1----4)- GlcCer]. Conclusions regarding the significance of these findings with respect to the biology of lung cancer await further information concerning the distribution of galactosylgloboside in normal and malignant tissues and the frequency of antibodies to this structure in normal and tumor-bearing individuals.

Full text

PDF
4441

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. W., Goodfellow P. N., Shevinsky L. H., Bronson D. L., Knowles B. B. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int J Cancer. 1982 May 15;29(5):523–531. doi: 10.1002/ijc.2910290507. [DOI] [PubMed] [Google Scholar]
  2. Bremer E. G., Levery S. B., Sonnino S., Ghidoni R., Canevari S., Kannagi R., Hakomori S. Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J Biol Chem. 1984 Dec 10;259(23):14773–14777. [PubMed] [Google Scholar]
  3. Cahan L. D., Irie R. F., Singh R., Cassidenti A., Paulson J. C. Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2. Proc Natl Acad Sci U S A. 1982 Dec;79(24):7629–7633. doi: 10.1073/pnas.79.24.7629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carey T. E., Takahashi T., Resnick L. A., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3278–3282. doi: 10.1073/pnas.73.9.3278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cote R. J., Morrissey D. M., Houghton A. N., Beattie E. J., Jr, Oettgen H. F., Old L. J. Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci U S A. 1983 Apr;80(7):2026–2030. doi: 10.1073/pnas.80.7.2026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cote R. J., Morrissey D. M., Houghton A. N., Thomson T. M., Daly M. E., Oettgen H. F., Old L. J. Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens. Proc Natl Acad Sci U S A. 1986 May;83(9):2959–2963. doi: 10.1073/pnas.83.9.2959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Damjanov I., Fox N., Knowles B. B., Solter D., Lange P. H., Fraley E. E. Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors. Am J Pathol. 1982 Aug;108(2):225–230. [PMC free article] [PubMed] [Google Scholar]
  8. Fenderson B. A., Andrews P. W., Nudelman E., Clausen H., Hakomori S. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev Biol. 1987 Jul;122(1):21–34. doi: 10.1016/0012-1606(87)90328-9. [DOI] [PubMed] [Google Scholar]
  9. Furukawa K., Clausen H., Hakomori S., Sakamoto J., Look K., Lundblad A., Mattes M. J., Lloyd K. O. Analysis of the specificity of five murine anti-blood group A monoclonal antibodies, including one that identifies type 3 and type 4 A determinants. Biochemistry. 1985 Dec 17;24(26):7820–7826. doi: 10.1021/bi00347a047. [DOI] [PubMed] [Google Scholar]
  10. HAKOMORI S. A RAPID PERMETHYLATION OF GLYCOLIPID, AND POLYSACCHARIDE CATALYZED BY METHYLSULFINYL CARBANION IN DIMETHYL SULFOXIDE. J Biochem. 1964 Feb;55:205–208. [PubMed] [Google Scholar]
  11. Hakomori S., Kannagi R. Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst. 1983 Aug;71(2):231–251. [PubMed] [Google Scholar]
  12. Hakomori S., Wang S. M., Young W. W., Jr Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer. Proc Natl Acad Sci U S A. 1977 Jul;74(7):3023–3027. doi: 10.1073/pnas.74.7.3023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Haspel M. V., McCabe R. P., Pomato N., Janesch N. J., Knowlton J. V., Peters L. C., Hoover H. C., Jr, Hanna M. G., Jr Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients. Cancer Res. 1985 Aug;45(8):3951–3961. [PubMed] [Google Scholar]
  14. Hirohashi S., Clausen H., Nudelman E., Inoue H., Shimosato Y., Hakomori S. A human monoclonal antibody directed to blood group i antigen: heterohybridoma between human lymphocytes from regional lymph nodes of a lung cancer patient and mouse myeloma. J Immunol. 1986 Jun 1;136(11):4163–4168. [PubMed] [Google Scholar]
  15. Kannagi R., Cochran N. A., Ishigami F., Hakomori S., Andrews P. W., Knowles B. B., Solter D. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J. 1983;2(12):2355–2361. doi: 10.1002/j.1460-2075.1983.tb01746.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kannagi R., Levery S. B., Ishigami F., Hakomori S., Shevinsky L. H., Knowles B. B., Solter D. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem. 1983 Jul 25;258(14):8934–8942. [PubMed] [Google Scholar]
  17. Knowles R. W., Bai Y., Daniels G. L., Watkins W. Monoclonal anti-type 2 H: an antibody detecting a precursor of the A and B blood group antigens. J Immunogenet. 1982 Apr;9(2):69–76. doi: 10.1111/j.1744-313x.1982.tb00965.x. [DOI] [PubMed] [Google Scholar]
  18. Magnani J. L., Smith D. F., Ginsburg V. Detection of gangliosides that bind cholera toxin: direct binding of 125I-labeled toxin to thin-layer chromatograms. Anal Biochem. 1980 Dec;109(2):399–402. doi: 10.1016/0003-2697(80)90667-3. [DOI] [PubMed] [Google Scholar]
  19. Mariani-Costantini R., Colnaghi M. I., Leoni F., Mènard S., Cerasoli S., Rilke F. Immunohistochemical reactivity of a monoclonal antibody prepared against human breast carcinoma. Virchows Arch A Pathol Anat Histopathol. 1984;402(4):389–404. doi: 10.1007/BF00734636. [DOI] [PubMed] [Google Scholar]
  20. Mènard S., Tagliabue E., Canevari S., Fossati G., Colnaghi M. I. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res. 1983 Mar;43(3):1295–1300. [PubMed] [Google Scholar]
  21. Pukel C. S., Lloyd K. O., Travassos L. R., Dippold W. G., Oettgen H. F., Old L. J. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med. 1982 Apr 1;155(4):1133–1147. doi: 10.1084/jem.155.4.1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sakamoto J., Furukawa K., Cordon-Cardo C., Yin B. W., Rettig W. J., Oettgen H. F., Old L. J., Lloyd K. O. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res. 1986 Mar;46(3):1553–1561. [PubMed] [Google Scholar]
  23. Sakamoto J., Yin B. W., Lloyd K. O. Analysis of the expression of H, Lewis, X, Y and precursor blood group determinants in saliva and red cells using a panel of mouse monoclonal antibodies. Mol Immunol. 1984 Nov;21(11):1093–1098. doi: 10.1016/0161-5890(84)90119-6. [DOI] [PubMed] [Google Scholar]
  24. Schwarting G. A., Carroll P. G., DeWolf W. C. Fucosyl-globoside and sialosyl-globoside are new glycolipids isolated from human teratocarcinoma cells. Biochem Biophys Res Commun. 1983 May 16;112(3):935–940. doi: 10.1016/0006-291x(83)91707-2. [DOI] [PubMed] [Google Scholar]
  25. Shevinsky L. H., Knowles B. B., Damjanov I., Solter D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell. 1982 Oct;30(3):697–705. doi: 10.1016/0092-8674(82)90274-4. [DOI] [PubMed] [Google Scholar]
  26. Shiku H., Takahashi T., Oettgen H. F. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med. 1976 Oct 1;144(4):873–881. doi: 10.1084/jem.144.4.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Springer G. F. T and Tn, general carcinoma autoantigens. Science. 1984 Jun 15;224(4654):1198–1206. doi: 10.1126/science.6729450. [DOI] [PubMed] [Google Scholar]
  28. Stern P. L. Differentiation antigens of teratomas and embryos. Br Med Bull. 1984 Jul;40(3):218–223. doi: 10.1093/oxfordjournals.bmb.a071980. [DOI] [PubMed] [Google Scholar]
  29. Tai T., Paulson J. C., Cahan L. D., Irie R. F. Ganglioside GM2 as a human tumor antigen (OFA-I-1). Proc Natl Acad Sci U S A. 1983 Sep;80(17):5392–5396. doi: 10.1073/pnas.80.17.5392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Yamaguchi H., Furukawa K., Fortunato S. R., Livingston P. O., Lloyd K. O., Oettgen H. F., Old L. J. Cell-surface antigens of melanoma recognized by human monoclonal antibodies. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2416–2420. doi: 10.1073/pnas.84.8.2416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yang H. J., Hakomori S. I. A sphingolipid having a novel type of ceramide and lacto-N-fucopentaose 3. J Biol Chem. 1971 Mar 10;246(5):1192–1200. [PubMed] [Google Scholar]
  32. Young W. W., Jr, Hakomori S. I., Levine P. Characterization of anti-Forssman (anti-Fs) antibodies in human sera: their specificity and possible changes in patients with cancer. J Immunol. 1979 Jul;123(1):92–96. [PubMed] [Google Scholar]
  33. Young W. W., Jr, Portoukalian J., Hakomori S. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J Biol Chem. 1981 Nov 10;256(21):10967–10972. [PubMed] [Google Scholar]
  34. Zanetta J. P., Breckenridge W. C., Vincendon G. Analysis of monosaccharides by gas-liquid chromatography of the O-methyl glycosides as trifluoroacetate derivatives. Application to glycoproteins and glycolipids. J Chromatogr. 1972 Jul 5;69(2):291–304. doi: 10.1016/s0021-9673(00)92897-8. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES